Targeting AAK1 has been shown to successfully prevent viral infection of cells74 and the compound baricitinib was recently suggested as potential drug to prevent endocytosis of SARS-CoV-2 by inhibiting AAK134. The gene discussed is AAK1; the disease is viral infectious disease.